| Record ID | marc_columbia/Columbia-extract-20221130-008.mrc:519586207:2126 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-008.mrc:519586207:2126?format=raw |
LEADER: 02126cam a2200469 a 4500
001 3962080
005 20221027010756.0
008 920103s1992 caua b 101 0 eng c
010 $a 91025955
020 $a0127022953
035 $a(OCoLC)24106706
035 $a(OCoLC)ocm24106706
035 $a(CStRLIN)NYCM92-B61
035 $9AFW1243HS
035 $a(NNC)3962080
035 $a3962080
040 $aDNLM/DLC$cDLC$dDLC$dNNC-M
050 00 $aRC271.C5$bD774 1991
060 0 $aQZ 267 D79358 1990
082 00 $a616.99/4061$220
245 00 $aDrug resistance as a biochemical target in cancer chemotherapy /$cedited by Takashi Tsuruo, Makoto Ogawa.
260 $aSan Diego :$bAcademic Press,$c1992.
300 $axxv, 342 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aBristol-Myers Squibb cancer symposia ;$v13
500 $aBased on the Bristol-Myers Squibb Drug Resistance in Cancer Symposium, held in Tokyo in 1990.
504 $aIncludes bibliographical references and index.
650 0 $aDrug resistance in cancer cells$vCongresses.
650 0 $aP-glycoprotein$vCongresses.
650 0 $aCancer$xChemotherapy$xComplications$vCongresses.
650 0 $aMultidrug resistance$vCongresses.
650 2 $aAntineoplastic Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D000970Q000494
650 2 $aDrug Resistance.$0https://id.nlm.nih.gov/mesh/D004351
650 2 $aGlycoproteins$xpharmacology.$0https://id.nlm.nih.gov/mesh/D006023Q000494
650 2 $aNeoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D009369Q000188
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aTsuruo, Takashi.$0http://id.loc.gov/authorities/names/n89143357
700 1 $aOgawa, M.$0http://id.loc.gov/authorities/names/n80165771
711 2 $aBristol-Myers Squibb Drug Resistance in Cancer Symposium$d(1990 :$cTokyo, Japan)$0http://id.loc.gov/authorities/names/n89143358
830 0 $aBristol-Myers Squibb cancer symposia ;$v13.$0http://id.loc.gov/authorities/names/n88525350
852 00 $boff,hsl$hRC271.C5$iD774 1992